GE HealthCare is set to introduce a groundbreaking technology focusing on improved workflow efficiency in mammography exams at the upcoming Radiological Society of North America (RSNA) conference. This new innovation, named the Pristina Via mammography platform, promises to revolutionize the way mammography is conducted by integrating advanced features designed to streamline the entire examination process.
A key highlight of the Pristina Via system is its ability to execute zero-click acquisition, which is a major step forward in simplifying the workflow during mammography assessments. This feature is expected to significantly reduce the time and effort required by technologists in managing imaging procedures, thereby allowing for a more patient-centric approach. In addition, the platform offers a seamless function for comparing prior images, supporting a comprehensive analysis regardless of the initial vendor of mammography systems used. This capability is critical in providing consistent and accurate assessments, ultimately improving the diagnostic journey for patients.
GE HealthCare also emphasizes that the Pristina Via system can notably enhance the efficiency of digital breast tomosynthesis (DBT), an advanced form of mammography. The image-to-image cycle time for DBT facilitated by Pristina Via is reportedly up to twice as fast as what is currently available from other mammography platforms. Such speedier processing not only expedites the imaging process but also optimizes the workflow for healthcare providers, ensuring that patient care is both swift and efficient. Furthermore, the system is carefully designed to deliver the lowest radiation dose across all breast thicknesses, addressing a critical concern of safety in mammographic procedures.
John Simon, M.D., who serves as the CEO of SimonMed, articulated the importance of these enhancements. He noted that by simplifying and automating the mammography exam process, there is significant potential to improve workflows within examination rooms, which is crucial in enhancing patient compliance and facilitating broader access to screening. He emphasized that the advancements brought about by the Pristina Via technology align perfectly with the overarching mission to make cutting-edge technology readily accessible to everyone.
With these transformative features, the Pristina Via mammography platform represents a significant milestone in elevating mammography exams. GE HealthCare’s commitment to innovation ensures that both healthcare providers and patients can benefit from this cutting-edge technology, fostering a more efficient, safer, and patient-friendly environment for breast cancer screening and diagnostic care.
About The Author
